Research

13 results.

May 19, 2025 Using viral mimicry to help the immune system see — and fight — cancer

Cancer cells are masters of disguise.

Like villains in bad movies, they evade detection by masquerading as healthy cells, turning off the body’s built-in alarm…

April 21, 2025 Pinpointing weaknesses in cancer’s armor

For scientists like Dr. Scott Rothbart, the same strategies that cancer cells use to survive also are powerful opportunities for developing new treatments.  

March 27, 2024 Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

GRAND RAPIDS, Mich. (March 27, 2024) — A pair of medications that make malignant cells act as if they have a virus could hold new promise for…

July 28, 2023 Alternative cellular ‘fuels’ boost immunity

GRAND RAPIDS, Mich. (July 28, 2023) — A metabolic by-product that is more prevalent during fasting may supercharge immune cells as they fight infection and…

May 11, 2023 Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers

GRAND RAPIDS, Mich. (May 11, 2023) — Van Andel Institute scientists have pinpointed how a specific gene mutation triggers an inflammatory cascade that may…

October 20, 2021 Meet the scientist behind the science: Dr. Scott Rothbart

Earlier today, we announced that Van Andel Institute Associate Professor Dr. Scott Rothbart has been awarded a Research Scholar Grant from…

VAI DEFAULT HEADER
October 20, 2021 American Cancer Society grant to support Van Andel Institute research into anti-cancer medications

GRAND RAPIDS, Mich. (Oct. 20, 2021) — Van Andel Institute’s Scott Rothbart, Ph.D., has earned a four-year, $792,000 Research…

September 22, 2021 Coriell Institute for Medical Research, Van Andel Institute awarded estimated $12.4 million SPORE grant from National Cancer Institute

Estimated at $12.4 million, this five-year grant supports a nationwide team of researchers investigating epigenetic therapies for cancer The Coriell Institute for Medical Research and…